EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

Patch Testing in Individuals With Diabetes Using Medical Devices. Part 1—Contact Allergy to Baseline Series Allergens

Thanisorn Sukakul, Josefin Ulriksdotter iD, Martin Mowitz iD, Magnus Bruze iD, Nils Hamnerius iD, Cecilia Svedman

Contact Dermatitis · 2026

DOI: 10.1111/cod.70117 ↗

At a glance

Journal article in Contact Dermatitis, 2026. Written by Thanisorn Sukakul and 5 co-authors. Institution: Department of Occupational and Environmental Dermatology, Lund University, Skåne University Hospital, Malmö, Sweden. Major MEDLINE topics: Dermatitis, Allergic Contact, Diabetes Mellitus, Type 1, Allergens, Insulin Infusion Systems. Cited 2 times so far (Crossref); 36 references. The full text is freely available (open access, CC BY 4.0). Funded by: The Stig and Ragna Gorthon Foundation, HudFonden, Svenska Diabetesstiftelsen.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

The prevalence of contact allergy in individuals with diabetes and diabetes medical device (MD) users is unknown.

Objectives

This study (Part 1 and 2) aims at describing contact allergy prevalences in diabetes MD users.

Methods

Adults with type 1 diabetes from two endocrinology departments were patch tested with the Swedish baseline series (SBS) and a MD series. Contact allergies to the baseline series were compared with consecutive dermatitis patients. Detailed results for the MD series are presented in another manuscript.

Results

Overall, similar contact allergy prevalences to the SBS were seen in the 204 individuals with diabetes (114 with rash to diabetes MDs, 90 without) and 1382 controls (34.3% vs. 39.6%, adjusted p value = 0.30). The prevalence of sesquiterpene lactone mix allergy was higher in the individuals with diabetes vs. dermatitis controls (2.5% vs. 0.3%, adjusted p value = 0.0011). Contact allergy to Myroxylon pereirae resin (MP) was overrepresented in individuals with diabetes versus controls (8.3% vs. 3.8%, adjusted p value = 0.0033) but not in individuals with diabetes with rash to diabetes MDs vs. without.

Conclusions

Contact allergy to the SBS is common in diabetes MD users. The cause of the overrepresentation of MP allergy needs to be further elucidated.

Subjects

MeSH terms (MEDLINE)

Dermatitis, Allergic ContactDiabetes Mellitus, Type 1AllergensInsulin Infusion SystemsHumansPatch TestsFemaleMaleMiddle AgedAdultPrevalenceBlood Glucose Self-MonitoringMyroxylonSwedenResins, PlantAgedLactonesCase-Control Studies

Author keywords

contact allergycontinuous glucose monitoringinsulin infusion systemstype 1 diabetes

Substances

AllergensResins, PlantLactones

Authors and institutions

  • Department of Occupational and Environmental Dermatology, Lund University, Skåne University Hospital, Malmö, Sweden.

ORCID profiles: Josefin Ulriksdotter, Martin Mowitz, Magnus Bruze, Nils Hamnerius

Funding

  • The Stig and Ragna Gorthon Foundation
  • HudFonden
  • Svenska Diabetesstiftelsen
  • Astma- och Allergiförbundet

Cite

APA

Sukakul, T., Ulriksdotter, J., Mowitz, M., Bruze, M., Hamnerius, N., & Svedman, C. (2026). Patch Testing in Individuals With Diabetes Using Medical Devices. Part 1—Contact Allergy to Baseline Series Allergens. Contact Dermatitis. https://doi.org/10.1111/cod.70117

Vancouver

Sukakul T, Ulriksdotter J, Mowitz M, Bruze M, Hamnerius N, Svedman C. Patch Testing in Individuals With Diabetes Using Medical Devices. Part 1—Contact Allergy to Baseline Series Allergens. Contact Dermatitis. 2026. doi:10.1111/cod.70117

BibTeX
@article{Sukakul2026,
  author = {Sukakul, Thanisorn and Ulriksdotter, Josefin and Mowitz, Martin and Bruze, Magnus and Hamnerius, Nils and Svedman, Cecilia},
  title = {Patch Testing in Individuals With Diabetes Using Medical Devices. Part 1—Contact Allergy to Baseline Series Allergens},
  journal = {Contact Dermatitis},
  year = {2026},
  doi = {10.1111/cod.70117}
}
Start for free →